Des dirigeants du CN prendront la parole lors de conférences à l’intention des investisseurs les 12, 20 et 21 février
February 06, 2019 11:30 ET
|
Canadian National Railway
MONTRÉAL, 06 févr. 2019 (GLOBE NEWSWIRE) -- Des cadres du CN (TSX : CNR) (NYSE : CNI) prendront la parole lors de trois conférences à l’intention des investisseurs qui ont lieu en...
CN leaders to address investor conferences on Feb.12, 20 and 21
February 06, 2019 11:30 ET
|
Canadian National Railway
MONTREAL, Feb. 06, 2019 (GLOBE NEWSWIRE) -- CN leaders (TSX: CNR) (NYSE: CNI), will address three investor conferences in February: Doug MacDonald, senior vice-president VP Rail-Centric Supply...
EVO Payments to Present at the Goldman Sachs Technology & Internet Conference
January 30, 2019 16:15 ET
|
EVO Payments, Inc.
ATLANTA, Jan. 30, 2019 (GLOBE NEWSWIRE) -- EVO Payments, Inc. (NASDAQ: EVOP) (“EVO”), a leading global payment technology and services provider, today announced that Kevin M. Hodges, Chief Financial...
Altair to Present at Needham Growth Conference
January 08, 2019 08:30 ET
|
Altair Engineering Inc.
TROY, Mich., Jan. 08, 2019 (GLOBE NEWSWIRE) -- Altair (NASDAQ:ALTR) Chief Financial Officer Howard Morof will present at the 21st Annual Needham Growth Conference to be held in New York, NY. The...
EVO Payments to Present at Upcoming Conferences
November 08, 2018 10:00 ET
|
EVO Payments, Inc.
ATLANTA, Nov. 08, 2018 (GLOBE NEWSWIRE) -- EVO Payments, Inc. (NASDAQ: EVOP) (“EVO”), a leading global provider of payment technology integration and acquiring solutions, today announced that James...
Jounce Therapeutics to Present at the 2018 Cantor Global Healthcare Conference
September 26, 2018 08:00 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
August 29, 2018 08:00 ET
|
Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
BioSyent to Present at Upcoming Investor Conference
August 24, 2018 12:00 ET
|
BioSyent Inc.
TORONTO, Aug. 24, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”) (TSX Venture: RX) is pleased to announce that it will be presenting at the Midwest IDEAS Investor Conference at...
Emergent BioSolutions to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference
June 08, 2018 06:30 ET
|
Emergent BioSolutions
GAITHERSBURG, Md., June 08, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that a member of the company’s senior management team will present a corporate overview and...
BioSyent to Present at Upcoming Investor Conferences
April 25, 2018 11:45 ET
|
BioSyent Inc.
TORONTO, April 25, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”) (TSX Venture:RX) is pleased to announce that it will be presenting at the following upcoming investor conferences: May 2, 2018...